Hot shot: the wider promise of weight-loss jabs
The Intelligence from The Economist
00:00
The Promise of GLP-1 Receptor Agonists
This chapter explores the transformative effects of GLP-1 receptor agonists, new weight-loss drugs initially developed for diabetes that may also improve heart health and other conditions. It highlights the ongoing research and broader potential applications of these medications, likening them to a 'Swiss army knife' for various health issues.
Transcript
Play full episode
